Press Releases

Net sales of $1,692.3 million; increase of 0.5%; organic decline of 0.4%Net income of $38.1 million; Adjusted EBITDA of $254.3 millionDiluted GAAP EPS of $0.06; adjusted EPS of $0.21Operating cash flow of $178.2 million; free cash flow of $142.8 millionIncreases FY 2026 organic revenue growth and adjusted EPS guidanceRADNOR, Pa., July 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports better than expected results for the second fiscal quarter of 2026. Emmanuel Ligner, President and C

Experienced Clarivate leader brings more than 25 years of financial and operational expertiseLONDON, July 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the appointment of Michael Easton as Executive Vice President and Chief Financial Officer, effective August 8, 2026. He succeeds Jonathan Collins who is stepping down as CFO to pursue another opportunity.   Mr. Easton is a tenured finance executive of the Company and brings more than 25 years of experience in finance, accounting and operations to the role. He most recen

Company Also Announces CFO Transition Plan; Tim Bixby, CFO, to Join Lemonade Board of Directors at Year End; Nick Stead, SVP Finance, to be Appointed Chief Financial OfficerNEW YORK, July 29, 2026 /PRNewswire/ -- Lemonade, Inc. (NYSE:LMND) today reported its second quarter 2026 financial results. You may view the financial results in Lemonade's Q2 2026 Letter to Shareholders, posted to its website. Today, Lemonade will host a conference call at 8:00 am Eastern time (5:00 am Pacific time) to discuss the results. To join the call, please dial in, toll-free at +1 833-461-5787, or at +1 585-542-9983; access code: 869 766 992.To joi

— Delivers continued progress on strategic and financial priorities through Value Creation Plan —— Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare segment divestiture —— Reaffirms 2026 financial outlook —LONDON, July 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2026. Executive CommentaryMatti Shem Tov, Chief Executive Officer: "The Value Creation Plan continues to drive meaningful progress, as we execute against our strateg

DIVIDEND DECLARATIONSNEW YORK, July 29, 2026 /PRNewswire/ -- Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced that its Board of Directors has declared a third quarter 2026 dividend of $0.48 per share. The third quarter 2026 dividend is payable on September 30, 2026 to stockholders of record as of September 15, 2026. JUNE 30, 2026 FINANCIAL RESULTS Ares Capital also announced financial results for its second quarter ended June 30, 2026.OPERATING RESULTSQ2-26(3)Q2-25(3)(dollar amounts in millions, except per share data)Total AmountPer ShareTotal AmountPer ShareGAAP net income per share(1)$   0.24$   0.52Core EPS(

Management Expects to Provide Preliminary 2027 Adjusted EBITDA Guidance and Additional Financial and Operating Metrics During August 4 Conference CallLAS VEGAS, July 29, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE:GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced preliminary unaudited financial results for the six months ended June 30, 2026. Based on preliminary results, the Company expects to report consolidated revenue for the first half of 2026 or approximately $80 million, an increase of approximately 57%, compared to approximately $51

Investment provides FLP with additional capital to support advisor growth, enhance the client experience, and accelerate the firm's national expansionLYNNFIELD, Mass., July 29, 2026 /PRNewswire/ -- F.L.Putnam Investment Management Company ("FLP") today announced that Bixby Wealth Solutions ("Bixby"), an arm of Moontower Group, has made a minority investment in the firm. Financial terms of the transaction were not disclosed. FLP manages more than $11 billion in assets for clients as of July 1, 2026, and has more than 165 employees located across 14 offices in the U.S. The firm will continue to operate independently and under the

RANCHO CUCAMONGA, Calif., July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company will release results for its second quarter of 2026 ended June 30, 2026, after the market closes on Thursday, August 6, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can also be accessed on the Investors page on the Company's website www.amphastar.com. The webcast replay of the call will be available

Subsequent transfer of Criteo's legal domicile from Luxembourg to U.S. is expected to be completed in January 2027NEW YORK, July 29, 2026 /PRNewswire/ -- Criteo S.A. (NASDAQ:CRTO) ("Criteo" or the "Company"), the global commerce intelligence platform, announced today the completion of the previously announced transfer of its legal domicile from France to Luxembourg via a cross-border conversion (the "Conversion"), effective July 29, 2026. In connection with the Conversion, the Company terminated its American Depositary Share ("ADS") program, and each holder of ADSs at the time of the Conversion mandatorily surrendered such ADSs, automatically receiving instead one ordinary share of the Compa

Management to host investor conference call at 8:30 a.m. ET on the same day to discuss resultsROSH HA'AIN, Israel, July 29, 2026 /PRNewswire/ -- Ceragon (NASDAQ:CRNT), a leading solutions provider of end-to-end wireless connectivity, announces that it will release its earnings results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, before the market opens. The Company will hold a Zoom webcast at 8:30 a.m. ET that same day to review the results, followed by a Q&A session. Investors may register for the call by clicking here. All relevant access details will be provided upon registration.For those unable t

Energy Fuels to build terbium (Tb) and dysprosium (Dy) oxide production capacity - one of the final steps in the Company's integrated mine-to-magnet platformDENVER, July 29, 2026 /CNW/ - Energy Fuels Inc. (NYSE:UUUU) (TSX:EFR), a leading U.S.-based critical materials company, today announced that construction has begun on an expansion of its White Mesa Mill in Utah (Mill) to enable the large-scale production of heavy rare earth oxides, which are planned to be used by Energy Fuels to produce rare earth metals, alloys and magnets essential to the automotive, robotics, data center, energy and defense industries. The expansion of the Company's existing light-rare earth oxide production capacity

On Track to Achieve Full Year Sales and Margin Targets 2Q Earnings and Margin Growth Include Benefit from Tariff RefundsRaises 2026 EPS and Free Cash Flow GuidanceReduced Debt by $1.7B and Executed $250M of Share Repurchases in 2QNEW BRITAIN, Conn., July 29, 2026 /PRNewswire/ -- Stanley Black & Decker (NYSE:SWK), a global leader in tools and outdoor solutions, today announced second quarter 2026 financial results.Second Quarter 2026 HighlightsNet sales of $4.0 billion, in-line with prior year and up 3% on an organic basis*Gross margin of 33.0%, up 600 basis points versus prior year; adjusted gross margin* of 33.7%, up 620 basis points versus prior year; both included a benefit of roughly 250

Grew Asset-Based revenue and improved Asset-Based profitability, with sequential margin expansion ahead of typical seasonality Grew Asset-Light revenue and volumes while maintaining cost discipline and improving productivity Advanced strategic priorities with the successful launch of ArcBest View™ and continued execution on operating efficiency initiatives ArcBest® (NASDAQ:ARCB), a leader in supply chain logistics, announced financial results for the second quarter ended June 30, 2026. Second quarter 2026 revenue totaled $1.2 billion, compared to $1.0 billion in the prior-year period. Net loss was $13.8 million, or $0.62 per diluted share, versus net income of $25.8 million, or

More than 20% of organizations reported a breach targeting AI models or applicationsARMONK, N.Y., July 29, 2026 /CNW/ -- One in four malicious breaches were AI-enabled – a 56% increase over last year – and these breaches cost an average of $6 million, roughly $1 million more than the global breach average of $4.99 million, according to IBM's 2026 Cost of a Data Breach Report. These attacks, compromised of mostly deepfake impersonation and AI-enabled malware, are reshaping breach economics. Attacks are getting faster and cheaper to launch, while breaches keep getting more expensive to find and fix. Companies that reported using

Energy becomes Canada's most expensive cyber target, while AI cuts breach costs by millionsThe average cost of a data breach in Canada reached a record CA$7.11 million.Energy became Canada's costliest cyber target, averaging CA$9.21 million per breach.Supply-chain compromise emerged as the largest breach driver, adding CA$368,000.Using AI extensively reduced breach costs by approximately CA$3.41 million.MARKHAM, ON, July 29, 2026 /CNW/ -- Canadian organizations are paying a record CA$7.11 million on average for a data breach, according to the 2026 IBM Cost of a Data Breach Report– the highest level recorded since the study began. The findings point to a shifting cyber risk landscape in Canad

Second Quarter 2026 Highlights (Compared to Second Quarter 2025): Net sales increased 5% to $1,530.7 million Organic Daily Sales increased 1% Gross profit increased 6% to $564.5 million; gross margin expanded 50 basis points to 36.9% SG&A as a percentage of Net sales increased 30 basis points to 24.2% Net income attributable to SiteOne increased 8% to $139.3 million Adjusted EBITDA1 increased 5% to $237.2 million; Adjusted EBITDA margin was 15.5% Cash provided by operating activities increased $16.5 million to $153.2 million Amended ABL Facility and extended maturity to April 2031 Repurchased $93.8 million of shares under the share repurchase authorization Acqu

Bunge Global SA (NYSE:BG) today reported second quarter 2026 results This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729712610/en/BG) today reported second quarter 2026 results.">Bunge Global SA (NYSE:BG) today reported second quarter 2026 results. Q2 GAAP diluted EPS of $3.47 vs. $2.61 in the prior year; $2.00 vs. $1.31 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Higher results primarily driven by strong performances in Soybean and Softseed Processing and Refining segments, supported by solid execution amid improving market conditions Repurchased ~$250 million of shares, c

Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis, $17.91 on an Adjusted basis 2Q26 Insurance segment GAAP benefit ratio of 91.2 percent, in line with management's guidance of 'slightly above 91 percent'; affirms full year (FY) 2026 Insurance segment benefit ratio guidance of 92.75 percent, plus or minus 25 basis points Affirms FY 2026 Adjusted EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $6.52' from the previous estimate of 'at least $8.36' Affirms FY 2026 individual Medicare Advantage (MA) membership growth of 'approximately 25 percent' over 2025;

The European Commission approval is based on Phase 3b TRuE‑AD4 data which demonstrated that Opzelura® (ruxolitinib) cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24, and was well tolerated 1,2,3 Incyte (NASDAQ:INCY) today announced that the European Commission (EC) has approved Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. "The European Commission's approval of Opzelura is an important milestone for adults in Europe living with moderate atopic dermatitis

PARIS, July 29, 2026 (GLOBE NEWSWIRE) -- Constellium SE (NYSE:CSTM) ("Constellium" or the "Company") today reported results for the second quarter and the first half ended June 30, 2026. Second quarter 2026 highlights: Shipments of 381 thousand metric tons, down 1% compared to Q2 2025Revenue of $2.7 billion, up 31% compared to Q2 2025Net income of $148 million compared to net income of $36 million in Q2 2025Adjusted EBITDA of $439 million     > Includes positive non-cash metal price lag impact of $129 millionSegment Adjusted EBITDA of $135 million at A&T, $165 million at P&ARP and $26 million at AS&I, partially offset by corporate costs of $(16) million, together representing a new quar